INSMED Inc Logo

INSMED Inc

Develops and commercializes innovative therapies for serious and rare diseases.

INSM | US

Overview

Corporate Details

ISIN(s):
US4576693075
LEI:
Country:
United States of America
Address:
700 US HIGHWAY 202/206, 8807 BRIDGEWATER
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Insmed Incorporated is a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. The company focuses on developing and commercializing innovative, first-in-class or best-in-class therapies to address significant unmet medical needs. Operating with a patient-centric mission, Insmed actively collaborates with and listens to patients and their families, incorporating their perspectives into its scientific research and clinical trial development. Its core strategy involves applying adaptive and agile scientific thinking to deliver impactful treatments for challenging conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all INSMED Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INSMED Inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INSMED Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Replek AD Logo
Manufactures & distributes generic medicines, supplements, and cosmetic products to over 25 countries.
North Macedonia REPL
Respiratorius AB Logo
Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.
Sweden RESP
REVELATION BIOSCIENCES, INC. Logo
Develops therapies that reprogram the innate immune system to reduce inflammation-related damage.
United States of America REVB
REVIVA PHARMACEUTICALS HOLDINGS, INC. Logo
Clinical-stage biopharma developing novel therapies for CNS, respiratory, and metabolic diseases.
United States of America RVPH
Revolution Medicines, Inc. Logo
A clinical-stage oncology company developing targeted therapies for RAS-addicted cancers.
United States of America RVMD
REVVITY, INC. Logo
Provides life sciences & diagnostics technologies to support workflows from discovery to cure.
United States of America RVTY
REYON PHARMACEUTICAL CO., LTD Logo
Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.
South Korea 102460
Rezolute, Inc. Logo
Developing therapies for rare metabolic diseases, focusing on hyperinsulinism-caused hypoglycemia.
United States of America RZLT
RHYTHM PHARMACEUTICALS, INC. Logo
Develops precision medicines for rare genetic diseases causing severe obesity and hyperphagia.
United States of America RYTM
RIGEL PHARMACEUTICALS INC Logo
Develops and commercializes small-molecule drugs for hematology, cancer, and autoimmune diseases.
United States of America RIGL

Talk to a Data Expert

Have a question? We'll get back to you promptly.